413 related articles for article (PubMed ID: 36675073)
21. Multifaceted Functional Role of Semaphorins in Glioblastoma.
Angelucci C; Lama G; Sica G
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052281
[TBL] [Abstract][Full Text] [Related]
22. Extracellular proteolysis in glioblastoma progression and therapeutics.
Quesnel A; Karagiannis GS; Filippou PS
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188428. PubMed ID: 32956761
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of EGFR Resistance in Glioblastoma.
Pan PC; Magge RS
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187135
[TBL] [Abstract][Full Text] [Related]
24. Current Development of Glioblastoma Therapeutic Agents.
Wang Z; Peet NP; Zhang P; Jiang Y; Rong L
Mol Cancer Ther; 2021 Sep; 20(9):1521-1532. PubMed ID: 34172531
[TBL] [Abstract][Full Text] [Related]
25. Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of Glioblastoma.
Krishna Moorthy N; Seifert O; Eisler S; Weirich S; Kontermann RE; Rehm M; Fullstone G
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946664
[TBL] [Abstract][Full Text] [Related]
26. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
[TBL] [Abstract][Full Text] [Related]
27. [Role of drug transporters in the central nervous system].
Erdő F; Temesszentandrási-Ambrus C; Beéry E
Orv Hetil; 2016 Mar; 157(10):370-8. PubMed ID: 26920327
[TBL] [Abstract][Full Text] [Related]
28. A role for caveola-forming proteins caveolin-1 and CAVIN1 in the pro-invasive response of glioblastoma to osmotic and hydrostatic pressure.
Pu W; Qiu J; Nassar ZD; Shaw PN; McMahon KA; Ferguson C; Parton RG; Riggins GJ; Harris JM; Parat MO
J Cell Mol Med; 2020 Mar; 24(6):3724-3738. PubMed ID: 32065471
[TBL] [Abstract][Full Text] [Related]
29. Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme?
Huysentruyt LC; Akgoc Z; Seyfried TN
ASN Neuro; 2011 Sep; 3(4):. PubMed ID: 21834792
[TBL] [Abstract][Full Text] [Related]
30. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse.
Williams MJ; Lowrie MB; Bennett JP; Firth JA; Clark P
Brain Res; 2005 Oct; 1058(1-2):62-72. PubMed ID: 16181616
[TBL] [Abstract][Full Text] [Related]
31. Potential clinical role of telomere length in human glioblastoma.
La Torre D; Aguennouz M; Conti A; Giusa M; Raffa G; Abbritti RV; Germano' A; Angileri FF
Transl Med UniSa; 2011 Sep; 1():243-70. PubMed ID: 23905037
[TBL] [Abstract][Full Text] [Related]
32. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
[TBL] [Abstract][Full Text] [Related]
33. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
34. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
[TBL] [Abstract][Full Text] [Related]
35. Tumour-associated glial host cells display a stem-like phenotype with a distinct gene expression profile and promote growth of GBM xenografts.
Leiss L; Mutlu E; Øyan A; Yan T; Tsinkalovsky O; Sleire L; Petersen K; Rahman MA; Johannessen M; Mitra SS; Jacobsen HK; Talasila KM; Miletic H; Jonassen I; Li X; Brons NH; Kalland KH; Wang J; Enger PØ
BMC Cancer; 2017 Feb; 17(1):108. PubMed ID: 28173797
[TBL] [Abstract][Full Text] [Related]
36. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.
Fukushima T; Tezuka T; Shimomura T; Nakano S; Kataoka H
J Biol Chem; 2007 Jun; 282(25):18634-18644. PubMed ID: 17475624
[TBL] [Abstract][Full Text] [Related]
37. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.
Simon T; Pinioti S; Schellenberger P; Rajeeve V; Wendler F; Cutillas PR; King A; Stebbing J; Giamas G
Mol Cancer; 2018 Aug; 17(1):132. PubMed ID: 30165850
[TBL] [Abstract][Full Text] [Related]
38. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
39. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.
Colarusso A; Maroccia Z; Parrilli E; Germinario EAP; Fortuna A; Loizzo S; Ricceri L; Tutino ML; Fiorentini C; Fabbri A
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32375387
[TBL] [Abstract][Full Text] [Related]
40. Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytoma.
Metellus P; Voutsinos-Porche B; Nanni-Metellus I; Colin C; Fina F; Berenguer C; Dussault N; Boudouresque F; Loundou A; Intagliata D; Chinot O; Martin PM; Figarella-Branger D; Ouafik L
Eur J Cancer; 2011 Jul; 47(11):1727-35. PubMed ID: 21458987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
